# Admin-Core-001

> **NIH NIH U2C** · WASHINGTON UNIVERSITY · 2022 · $28,540

## Abstract

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research. Our focus is on rare and understudied cancer populations with significant disparities including cholangiocarcinoma, multiple myeloma, and colorectal cancer under age 50. Participant engagement strategies are most effective when they are adapted and implemented in real-world settings in partnership with community and patient advocacy stakeholders.

## Key facts

- **NIH application ID:** 10709107
- **Project number:** 3U2CCA252981-02S1
- **Recipient organization:** WASHINGTON UNIVERSITY
- **Principal Investigator:** GRAHAM A. COLDITZ
- **Activity code:** U2C (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $28,540
- **Award type:** 3
- **Project period:** 2022-09-01 → 2026-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10709107

## Citation

> US National Institutes of Health, RePORTER application 10709107, Admin-Core-001 (3U2CCA252981-02S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10709107. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*